NATURAL GROCERS BY VITAMIN C
NGVCNYSE🏆 #2345 by market capEarnings Nov 19US Equity
$27.62▲ $1.37 (+4.96%)
Market closed · at close1h—
24h▲ 5.0%
7d▼ 13.9%
14d▼ 15.1%
30d▼ 15.4%
1y▼ 31.9%
🏦Market Cap
$636M
Small Cap
📈Revenue Growth (YoY)
+3.1%
Slowing
📊Gross Margin
29.8%
Moderate
💵FCF Margin
1.6%
Thin
⚖️P/S Ratio
0.5x
Cheap
Otter Score
54
Weak
📊
Analyst Ratings
Price
$27.62
Total
16
Raised
6
Lowered
2
Avg PT
$40.00
H / L
$40 / $40
| Institution | Action | Rating | Date |
|---|---|---|---|
Wolfe Research | Reiterated | Outperform | 2020-10-09 |
Citigroup | Reiterated | Buy | 2018-09-18 |
RBC Capital | Upgraded | Sector Perform → Outperform | 2018-01-31 |
Deutsche Bank | Reiterated | Hold | 2017-11-17 |
SunTrust Robinson Humphrey | Downgraded | Buy → Hold | 2017-02-03 |
Jefferies | Downgraded | Buy → Hold | 2017-01-31 |
Barclays | Reiterated | Equal Weight | 2016-09-23 |
Wedbush | Upgraded | Underperform → Neutral | 2015-08-04 |
Stephens & Co. | Upgraded | Equal Weight → Overweight | 2015-06-05 |
PiperJaffray | Upgraded | Neutral → Overweight | 2015-01-23 |
Piper Sandler | Upgraded | Neutral → Overweight | 2015-01-23 |
Oppenheimer | Reiterated | Perform | 2014-10-13 |
Imperial Capital | Upgraded | In Line → Outperform | 2014-05-05 |
Wells Fargo | Reiterated | Outperform | 2013-09-09 |
Longbow Research | Reiterated | Neutral | 2013-04-30 |
Canaccord Genuity | Reiterated | Buy | 2012-09-17 |
One row per institution, most recent rating